Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour Source: Eur Respir J, 59 (1) 2101058; 10.1183/13993003.01058-2021 Year: 2022
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome Source: Eur Respir J 2016; 47:1829-1841 Year: 2016
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the role of neuroendocrine cells in airway remodelling Source: Annual Congress 2003 - The vital role of neuroendocrine cells in lung development and neoplasia Year: 2003
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. 7-year follow-up of a rare clinicopathologic syndrome Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012
Constrictive bronchiolitis in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia Source: ERJ Open Res, 6 (4) 00527-2020; 10.1183/23120541.00527-2020 Year: 2020
Diffuse idiopathic pulmonary neuroendocrine hyperplasia, chronic eosinophilic pneumonia, and asthma Source: Eur Respir J 2009; 34: 1489-1492 Year: 2009
Progress in the pathology of diffuse lung disease in infancy: changing concepts and diagnostic challenges Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=21 Year: 2007
The differential diagnosis of pulmonary pre-invasive lesions Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=37 Year: 2007
Langerhans’ cell granulomatosis: clinical manifestations and prognosis of pulmonary lesions Source: Eur Respir J 2004; 24: Suppl. 48, 49s Year: 2004
Analysis of the clinical and pathological features of 10 patients with pulmonary sclerosing hemangioma Source: Eur Respir J 2005; 26: Suppl. 49, 538s Year: 2005
Clinical and morphologic features of focal and diffuse pulmonary leiomyomatosis Source: Annual Congress 2004 - Pathobiological and clinical investigations in interstitial lung diseases Year: 2004
An unusual case of diffuse pulmonary meningotheliomatosis accompanying with cystic lung disease Source: International Congress 2019 – Interstitial lung diseases? Year: 2019
Diffuse idiopathic pulmonary endocrine cell hyperplasia (DIPNECH) requiring bilateral sequential lung transplant Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013
Lymphoid hyperplasia and eosinophilic pneumonia as histologic manifestations of amiodarone-induced lung toxicity Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011
Two different clinical forms of pulmonary langerhans cell granulomatosis Source: Eur Respir J 2002; 20: Suppl. 38, 471s Year: 2002
Immunophenotypic profiles of lung carcinomas associated with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008
Comparison of clinical characteristics and prognosis in patients with idiopathic pulmonary upper lobe predominant pulmonary fibrosis and idiopathic pulmonary fibrosis Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018
Synchronous multiple primary lung cancers manifesting as multiple ground-glass nodules define a special clinical subtype Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020
Clinical and pathological features of 13 adult patients with pulmonary Langerhans‘ cell histiocytosis Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009
Depiction of malignancy in patients with diffuse interstitial lung disease (DILD) presenting with nodular opacities Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008